Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
54.80
+0.15 (0.27%)
Feb 21, 2025, 5:35 PM CET
BME:ROVI Revenue
Laboratorios Farmaceuticos Rovi had revenue of 235.28M EUR in the quarter ending September 30, 2024, with 9.93% growth. This brings the company's revenue in the last twelve months to 799.25M, down -4.52% year-over-year. In the year 2023, Laboratorios Farmaceuticos Rovi had annual revenue of 829.51M with 1.44% growth.
Revenue (ttm)
799.25M
Revenue Growth
-4.52%
P/S Ratio
3.66
Revenue / Employee
378.61K
Employees
2,111
Market Cap
2.80B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 829.51M | 11.81M | 1.44% |
Dec 31, 2022 | 817.70M | 169.02M | 26.06% |
Dec 31, 2021 | 648.68M | 228.72M | 54.46% |
Dec 31, 2020 | 419.96M | 38.65M | 10.14% |
Dec 31, 2019 | 381.31M | 78.11M | 25.76% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grifols | 7.01B |
Almirall | 953.49M |
Pharma Mar | 167.00M |
Faes Farma | 504.04M |
Clínica Baviera | 252.47M |
Atrys Health | 211.11M |
Laboratorio Reig Jofre | 333.69M |
Prim, S.A. | 227.57M |